men-generics.ru


ABBV STOCK FORECAST 2022

A high-level overview of AbbVie Inc. (ABBV) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for is USD. With a 5-year investment, the revenue. Industrials are not as over-owned as energy was, but they are one of the most vulnerable groups out there. AMGNEOGABBV · Actions & Analysis. Nov 13, The volatility of related hype on AbbVie is about % with expected price after next announcement by competition of About % of the company. 13 Wall Street analysts have issued twelve-month price targets for AbbVie's shares. Their ABBV share price targets range from $ to $ On average.

Stock Price Targets ; High, $ ; Median, $ ; Low, $ ; Average, $ ; Current Price, $ PRE MARKET AM EST 03/07/24 · % · PRE MARKET Vol According to the algorithm-based forecaster Wallet Investor in its Abbvie stock forecast for , the price could reach $ by the end of December. Earnings Per Share: For , AbbVie reported full-year diluted EPS of $ on a GAAP basis and adjusted diluted EPS of $, up %. For , AbbVie. The all-time high AbbVie stock closing price was on March 06, The AbbVie week high stock price is , which is 2% above the current share. The high in the last 52 weeks of AbbVie stock was According to the current price, AbbVie is % away from the week high. What are analysts. AbbVie Stock Smart Score ; Analyst Consensus. Moderate Buy. Average Price Target: $ (% Downside) ; Blogger Sentiment. Bullish. ABBV Sentiment 90%. AbbVie annual revenue for was $B, a % increase from AbbVie annual revenue for was $B, a % increase from In depth view into ABBV (AbbVie) stock including the latest price, news, dividend history, earnings information and financials. AbbVie is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on equity is. Get AbbVie Inc (ABBV.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

According to 13 analysts, the average rating for ABBV stock is "Buy." The month stock price forecast is $, which is an increase of % from the. ABBVAbbVie Inc. + (+%). At close: Find the latest AbbVie Inc (ABBV) stock forecast, month price target, predictions and analyst recommendations. AbbVie stock price forecast: $; Market Cap: B, Enterprise value: B, P/E: , PEG ratio: , EPS: , Revenue: B. The 11 analysts with month price forecasts for AbbVie stock have an average target of , with a low estimate of and a high estimate of The. While ratings are subjective and will change, the latest AbbVie (ABBV) rating was a maintained with a price target of $ to $ The current price. The average twelve-month price prediction for AbbVie is $ with a high price target of $ and a low price target of $ Learn more on ABBV's. See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. AbbVie Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range -

AbbVie Inc Frequently Asked Questions · What is AbbVie Inc(ABBV)'s stock price today? The current price of ABBV is $ · When is next earnings date of AbbVie. The Abbvie stock prediction for is currently $ , assuming that Abbvie shares will continue growing at the average yearly rate as they did in the last. OPEN. ; PREV. CLOSE. ; VOLUME. 6,, ; MARKET CAP. B ; DAY RANGE. More Lists. AbbVie Financial Summary. Select list year. Revenue. $B. Assets. $B. Price, , Change ; Volume, 1,,, % Change ; Intraday High, , 52 Week High ; Intraday Low, , 52 Week Low.

BTFP Explained \u0026 Weekly Finance Forecast (Bank Term Funding Program?)

0 20, 40, 60, 80, % % % % % ©men-generics.ru - S&P Global Market Intelligence. Loading.

unvr | intel stock price forecast in 5 years

11 12 13 14 15

Copyright 2017-2024 Privice Policy Contacts SiteMap RSS